CHTP Stock News 6.57 05/09/2014 19:32:47 Chelsea Therapeutics
Post# of 273322
Posted On: 05/09/2014 8:32:49 PM
Chelsea Therapeutics International (CHTP) 6.57 $CHTP
Lifshitz & Miller Law Firm Announces Investigation of Chelsea Therapeutics International Ltd., KBR, Inc., OmniAmerican Bancorp, Inc., PokerTek, Inc., SP Bancorp, Inc. and 1st United Bancorp, Inc.
PR Newswire - 41 mins ago
Chelsea Therapeutics International Ltd.
Nasdaq stocks posting largest volume increases
AP - 2 hrs 28 mins ago
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
Nasdaq stocks posting largest percentage increases
AP - 2 hrs 28 mins ago
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
Most active Nasdaq-traded stocks
AP - 2 hrs 28 mins ago
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of Chelsea Therapeutics International, Ltd. and Its Board of Directors In Connection With the Sale of the Company to H. Lundbeck A/S
Business Wire - Fri May 09, 3:35PM CDT
Levi & Korsinsky is investigating the Board of Directors of Chelsea Therapeutics International, Ltd. ("Chelsea Therapeutics" or "the Company"
(NasdaqCM:CHTP) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to H. Lundbeck A/S.
Ryan & Maniskas, LLP Announces Investigation of Chelsea Therapeutics International Ltd.
PR Newswire - Fri May 09, 9:35AM CDT
Ryan & Maniskas, LLP is investigating potential claims against the board of directors of Chelsea Therapeutics International Ltd. ("Chelsea Therapeutics" or the "Company" (NASDAQ: CHTP) concerning possible breaches of fiduciary duty and other violations of law related to the Company's efforts to sell the Company to H. Lundbeck A/S in a transaction valued at approximately $658 million.
Chelsea Therapeutics International Shares Up 30.1% Since SmarTrend's Buy Recommendation (CHTP)
Comtex SmarTrend(R) - Fri May 09, 9:13AM CDT
SmarTrend identified an Uptrend for Chelsea Therapeutics International (NASDAQ:CHTP) on January 15th, 2014 at $5.03. In approximately 4 months, Chelsea Therapeutics International has returned 30.12% as of today's recent price of $6.55.
Newman Ferrara LLP Announces Investigation of Chelsea Therapeutics International Ltd.
Business Wire - Fri May 09, 9:08AM CDT
Newman Ferrara LLP is investigating potential claims against the board of directors of Chelsea Therapeutics International ("Chelsea" (Nasdaq: CHTP) concerning the proposed sale of Chelsea to Danish corporation H. Lundbeck A/S ("Lundbeck".
Law Offices of Marc S. Henzel Announces Securities Class Action Periods
PR Newswire - Fri May 09, 8:11AM CDT
The Law Offices of Marc S. Henzel (www.henzellaw.com) a firm focusing on shareholder litigation, gives notice to purchasers of the following securities for the following class periods:
Chelsea Therapeutics International Ltd. (CHTP) Looks Strong as Stock Shoots up 31.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri May 09, 7:44AM CDT
Chelsea Therapeutics International Ltd. (CHTP) was a big mover last session, as the company saw its shares soar 31.6% on the day.
SHAREHOLDER ALERT: Brower Piven Announces the Investigation of Chelsea Therapeutics International, Ltd. in Connection with the Proposed Sale of the Company to H. Lundbeck A/S
Business Wire - Thu May 08, 8:00PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty to current shareholders of Chelsea Therapeutics International, Ltd. ("Chelsea" or the "Company" (NasdaqCM: CHTP) and other violations of state law by the board of directors of Chelsea relating to the proposed buyout of the Company by H. Lundbeck A/S ("Lundbeck".
CHELSEA THERAPEUTICS ALERT: Johnson & Weaver Investigating the Proposed Sale of Chelsea Therapeutics International, Ltd.
Business Wire - Thu May 08, 7:45PM CDT
Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of Chelsea Therapeutics International, Ltd. (NASDAQ: CHPT) breached their fiduciary duties in connection with the proposed sale of the Company to H. Ludbeck A/S.
Why Groupon, CenturyLink, and Chelsea Therapeutics Jumped Today
Dan Caplinger, The Motley Fool - Motley Fool - Thu May 08, 7:05PM CDT
On Thursday, investors paid close attention to whether the stock market would rise to new record highs, as the final big push of earnings season included positive reports from some major companies. Yet in the end, broader concerns about the...
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Chelsea Therapeutics International, Ltd. Stockholders
Business Wire - Thu May 08, 5:35PM CDT
Kirby McInerney LLP is investigating potential claims against the Board of Directors of Chelsea Therapeutics International, Ltd. ("Chelsea Therapeutics" or the "Company" (NASDAQ: CHTP) concerning the proposed acquisition of the Company by H. Lundbeck A/S ("Lundbeck". Under the terms of the definitive merger agreement, Chelsea Therapeutics stockholders will receive $6.44 in cash and up to $1.50 in Contingent Value Rights for each share of Chelsea Therapeutics owned, representing a total potential consideration of up to $658 million.
SHAREHOLDER ALERT: The Law Office of James C. Kelly Investigates Claims That the Proposed Acquisition of Chelsea Therapeutics International, Ltd. May Not Be in its Investors' Best Interests
PR Newswire - Thu May 08, 4:25PM CDT
The Law Office of James C. Kelly is investigating claims on behalf of investors of Chelsea Therapeutics International, Ltd. ("Chelsea" or the "Company" (NASDAQ: CHTP), concerning the proposed acquisition of Chelsea by H. Lundbeck A/S ("Lundbeck". Chelsea shareholders seeking more information about this acquisition are advised to contact James C. Kelly at 888.643.7517 or jkelly@jckellylaw.com.
Why Chelsea Therapeutics, Keurig Green Mountain, and SolarCity Are Today's 3 Best Stocks
Sean Williams, The Motley Fool - Motley Fool - Thu May 08, 4:15PM CDT
In spite of generally positive economic data, and spending much of the day in positive territory, the broad-based S&P 500 finished the day modestly lower, dragged down by a combination of profit-taking, as well as number of high-profile...
INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of Chelsea Therapeutics International, Ltd. and Its Board of Directors In Connection With the Sale of the Company to H. Lundbeck A/S -- CHTP
PR Newswire - Thu May 08, 4:09PM CDT
Levi & Korsinsky is investigating the Board of Directors of Chelsea Therapeutics International, Ltd. ("Chelsea Therapeutics" or "the Company" (NasdaqCM: CHTP) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to H. Lundbeck A/S.
After Yesterday's Rally of 31.60% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Thu May 08, 3:43PM CDT
Chelsea Therapeutics International (NASDAQ:CHTP) traded in a range yesterday that spanned from a low of $6.46 to a high of $6.60. Yesterday, the shares gained 31.6%, which took the trading range above the 3-day high of $5.25 on volume of 66.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
Lifshitz & Miller Law Firm Announces Investigation of Chelsea Therapeutics International Ltd., KBR, Inc., OmniAmerican Bancorp, Inc., PokerTek, Inc., SP Bancorp, Inc. and 1st United Bancorp, Inc.
PR Newswire - 41 mins ago
Chelsea Therapeutics International Ltd.
Nasdaq stocks posting largest volume increases
AP - 2 hrs 28 mins ago
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
Nasdaq stocks posting largest percentage increases
AP - 2 hrs 28 mins ago
NEW YORK (AP) — A look at the 10 biggest percentage gainers on Nasdaq at the close of trading:
Most active Nasdaq-traded stocks
AP - 2 hrs 28 mins ago
NEW YORK (AP) — A look at Nasdaq 10 most-active stocks at the close of trading:
INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of Chelsea Therapeutics International, Ltd. and Its Board of Directors In Connection With the Sale of the Company to H. Lundbeck A/S
Business Wire - Fri May 09, 3:35PM CDT
Levi & Korsinsky is investigating the Board of Directors of Chelsea Therapeutics International, Ltd. ("Chelsea Therapeutics" or "the Company"
(NasdaqCM:CHTP) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to H. Lundbeck A/S. Ryan & Maniskas, LLP Announces Investigation of Chelsea Therapeutics International Ltd.
PR Newswire - Fri May 09, 9:35AM CDT
Ryan & Maniskas, LLP is investigating potential claims against the board of directors of Chelsea Therapeutics International Ltd. ("Chelsea Therapeutics" or the "Company"
(NASDAQ: CHTP) concerning possible breaches of fiduciary duty and other violations of law related to the Company's efforts to sell the Company to H. Lundbeck A/S in a transaction valued at approximately $658 million. Chelsea Therapeutics International Shares Up 30.1% Since SmarTrend's Buy Recommendation (CHTP)
Comtex SmarTrend(R) - Fri May 09, 9:13AM CDT
SmarTrend identified an Uptrend for Chelsea Therapeutics International (NASDAQ:CHTP) on January 15th, 2014 at $5.03. In approximately 4 months, Chelsea Therapeutics International has returned 30.12% as of today's recent price of $6.55.
Newman Ferrara LLP Announces Investigation of Chelsea Therapeutics International Ltd.
Business Wire - Fri May 09, 9:08AM CDT
Newman Ferrara LLP is investigating potential claims against the board of directors of Chelsea Therapeutics International ("Chelsea"
(Nasdaq: CHTP) concerning the proposed sale of Chelsea to Danish corporation H. Lundbeck A/S ("Lundbeck". Law Offices of Marc S. Henzel Announces Securities Class Action Periods
PR Newswire - Fri May 09, 8:11AM CDT
The Law Offices of Marc S. Henzel (www.henzellaw.com) a firm focusing on shareholder litigation, gives notice to purchasers of the following securities for the following class periods:
Chelsea Therapeutics International Ltd. (CHTP) Looks Strong as Stock Shoots up 31.6% - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Fri May 09, 7:44AM CDT
Chelsea Therapeutics International Ltd. (CHTP) was a big mover last session, as the company saw its shares soar 31.6% on the day.
SHAREHOLDER ALERT: Brower Piven Announces the Investigation of Chelsea Therapeutics International, Ltd. in Connection with the Proposed Sale of the Company to H. Lundbeck A/S
Business Wire - Thu May 08, 8:00PM CDT
The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty to current shareholders of Chelsea Therapeutics International, Ltd. ("Chelsea" or the "Company"
(NasdaqCM: CHTP) and other violations of state law by the board of directors of Chelsea relating to the proposed buyout of the Company by H. Lundbeck A/S ("Lundbeck". CHELSEA THERAPEUTICS ALERT: Johnson & Weaver Investigating the Proposed Sale of Chelsea Therapeutics International, Ltd.
Business Wire - Thu May 08, 7:45PM CDT
Shareholder rights law firm Johnson & Weaver, LLP has launched an investigation into whether the board members of Chelsea Therapeutics International, Ltd. (NASDAQ: CHPT) breached their fiduciary duties in connection with the proposed sale of the Company to H. Ludbeck A/S.
Why Groupon, CenturyLink, and Chelsea Therapeutics Jumped Today
Dan Caplinger, The Motley Fool - Motley Fool - Thu May 08, 7:05PM CDT
On Thursday, investors paid close attention to whether the stock market would rise to new record highs, as the final big push of earnings season included positive reports from some major companies. Yet in the end, broader concerns about the...
Law Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Chelsea Therapeutics International, Ltd. Stockholders
Business Wire - Thu May 08, 5:35PM CDT
Kirby McInerney LLP is investigating potential claims against the Board of Directors of Chelsea Therapeutics International, Ltd. ("Chelsea Therapeutics" or the "Company"
(NASDAQ: CHTP) concerning the proposed acquisition of the Company by H. Lundbeck A/S ("Lundbeck". Under the terms of the definitive merger agreement, Chelsea Therapeutics stockholders will receive $6.44 in cash and up to $1.50 in Contingent Value Rights for each share of Chelsea Therapeutics owned, representing a total potential consideration of up to $658 million. SHAREHOLDER ALERT: The Law Office of James C. Kelly Investigates Claims That the Proposed Acquisition of Chelsea Therapeutics International, Ltd. May Not Be in its Investors' Best Interests
PR Newswire - Thu May 08, 4:25PM CDT
The Law Office of James C. Kelly is investigating claims on behalf of investors of Chelsea Therapeutics International, Ltd. ("Chelsea" or the "Company"
(NASDAQ: CHTP), concerning the proposed acquisition of Chelsea by H. Lundbeck A/S ("Lundbeck". Chelsea shareholders seeking more information about this acquisition are advised to contact James C. Kelly at 888.643.7517 or jkelly@jckellylaw.com. Why Chelsea Therapeutics, Keurig Green Mountain, and SolarCity Are Today's 3 Best Stocks
Sean Williams, The Motley Fool - Motley Fool - Thu May 08, 4:15PM CDT
In spite of generally positive economic data, and spending much of the day in positive territory, the broad-based S&P 500 finished the day modestly lower, dragged down by a combination of profit-taking, as well as number of high-profile...
INVESTOR ALERT: Levi & Korsinsky, LLP Announces Investigation of Chelsea Therapeutics International, Ltd. and Its Board of Directors In Connection With the Sale of the Company to H. Lundbeck A/S -- CHTP
PR Newswire - Thu May 08, 4:09PM CDT
Levi & Korsinsky is investigating the Board of Directors of Chelsea Therapeutics International, Ltd. ("Chelsea Therapeutics" or "the Company"
(NasdaqCM: CHTP) for possible breaches of fiduciary duty and other violations of state law in connection with the sale of the Company to H. Lundbeck A/S. After Yesterday's Rally of 31.60% Shares Could Potentially Pullback
Comtex SmarTrend(R) - Thu May 08, 3:43PM CDT
Chelsea Therapeutics International (NASDAQ:CHTP) traded in a range yesterday that spanned from a low of $6.46 to a high of $6.60. Yesterday, the shares gained 31.6%, which took the trading range above the 3-day high of $5.25 on volume of 66.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
(0)
(0)